- CSP Management Ltd and affiliates sent a non-binding proposal to StarTek, Inc (NYSE:SRT) to acquire all the shares of Startek that CSP does not already own for $4.65 per share in cash.
- The offer price implies a 41.8% premium on StarTek’s August 8 closing price of $3.28.
- CSP is currently the beneficial owner of 56% of the outstanding shares of Startek.
- This new proposal constitutes a revision of CSP’s non-binding proposal, dated December 20, 2021, to acquire all the shares of Startek for $5.40 per share in cash.
- CSP failed to arrange a debt and equity financing package on terms acceptable to CSP for its proposal, dated December 20, 2021.
- Price Action: SRT shares traded higher by 11.90% at $3.67 on the last check Tuesday.
Mydecine’s Q3 Financials & Update, Sustained Target On Smoking Cessation For Next 12 Months
Mydecine Innovations Group (OTC: MYCOF), the psychedelics biotech company headquartered in Denver, Colorado with international offices in the Netherlands, reported its financial results and business highlights for the three and nine months ended September 30, 2022.
